Physician profile
Kathleen M Duerksen
NPI 1417966607
$5,100.00
in general payments reported to CMS, 2019-2025
24 companies · $749 in 2025
The $749 reported for 2025 was more than what a typical Ophthalmic Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $299).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,293 · 2020: $91.52 · 2021: $520 · 2022: $851 · 2023: $1,014 · 2024: $582 · 2025: $749.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,344.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $820.12 | 2019-2023 | Tepezza |
| Ventana Medical Systems, INC. | $552.29 | 2019 | |
| Galderma Laboratories, L.P. | $535.61 | 2019-2024 | |
| Abbvie INC. | $479.14 | 2023-2025 | Durysta |
| Merz North America, INC. | $374.58 | 2021-2025 | |
| Amgen INC. | $266.59 | 2024-2025 | Tepezza |
| Regeneron Healthcare Solutions, INC. | $239.05 | 2023-2024 | Libtayo |
| Allergan, INC. | $196.76 | 2022 | |
| Integra Lifesciences Corporation | $187.37 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Mallinckrodt Hospital Products INC. | $145.81 | 2025 | Acthar |
| Smith+Nephew, INC. | $136.26 | 2023 | Grafix Pl |
| Rxsight INC | $134.41 | 2022 | |
| Biotissue Holdings INC. | $128.91 | 2021 | |
| Alcon Vision LLC | $125.00 | 2022 | |
| Glaukos Corporation | $124.08 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $122.56 | 2022 | |
| Novartis Pharmaceuticals Corporation | $116.58 | 2019 | |
| Alafair Biosciences, INC. | $91.24 | 2025 | Versawrap |
| Silk Road Medical, INC. | $86.95 | 2019 | |
| Depuy Synthes Sales INC. | $84.87 | 2023 | Matrixcombo |
| Genentech USA, INC. | $57.01 | 2019 | |
| Abbott Laboratories | $48.12 | 2023 | Mitraclip |
| Apyx Medical Corporation | $35.13 | 2020 | |
| Ocular Therapeutix, INC. | $11.56 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Duerksen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.